Deciphering the mode of action of the synthetic antimicrobial peptide bac8c

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 4, 2011, Pages 1706-1716

  Spindler, E C ^a   Hale, J D F ^b   Giddings Jr , T H ^a   Hancock, R E W ^b   Gill, R T ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTENECIN; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; FREE RADICAL; METHYLGLYOXAL; PEPTIDE BAC8C; POLYPEPTIDE ANTIBIOTIC AGENT; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL MEMBRANE; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; CELL DEATH; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; COLONY FORMING UNIT; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CONVALESCENCE; DRUG MECHANISM; ELECTRON TRANSPORT; ESCHERICHIA COLI; FLOW CYTOMETRY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOST RESISTANCE; MEMBRANE DEPOLARIZATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTON MOTIVE FORCE; RESPIRATORY FUNCTION; TRANSMISSION ELECTRON MICROSCOPY;

ANTI-BACTERIAL AGENTS; ESCHERICHIA COLI; FLOW CYTOMETRY; HYDROXYL RADICAL; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, TRANSMISSION; PEPTIDES; PEPTIDES, CYCLIC;

EID: 79953230877     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01053-10     Document Type: Article

References (47)

1. Booth, I. R., et al. 2003. Bacterial production of methylglyoxal: a survival strategy or death by misadventure? Biochem. Soc. Transact. 31:1406-1408.
2. Brogden, K. A. 2005. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3:238-250.
3. Bryan, L. E., and S. Kwan. 1983. Roles of ribosomal binding, membrane potential, and electron transport in bacterial uptake of streptomycin and gentamicin. Antimicrob. Agents Chemother. 23:835-845.
4. Damper, P. D., and W. Epstein. 1981. Role of the membrane potential in bacterial resistance to aminoglycoside antibiotics. Antimicrob. Agents Chemother. 20:803-808.
5. Farr, S. B., and T. Kogoma. 1991. Oxidative stress responses in Escherichia coli and Salmonella typhimurium. Microbiol. Rev. 55:561-585.
6. Friedrich, C. L., D. Moyles, T. J. Beveridge, and R. E. W. Hancock. 2000. Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria. Antimicrob. Agents Chemother. 44:2086-2092.
7. Gennis, R. B., and V. Stewart. 1996. Respiration, p. 217-261. In F. C. Neidhardt et al. (ed.), Escherichia Coli and Salmonella: cellular and molecular biology, vol. 1. Asm Press, Washington, DC.
8. Gonzalez-Flecha, B., and B. Demple. 1995. Metabolic sources of hydrogen peroxide in aerobically growing Escherichia coli. J. Biol. Chem. 270:13681-13687.
9. Hale, J. D., and R. E. Hancock. 2007. Alternative mechanisms of action of cationic antimicrobial peptides on bacteria. Expert Rev. Anti Infect. Ther. 5:951-959.
10. Hancock, R. E. W., and D. S. Chapple. 1999. Peptide antibiotics. Antimicrob. Agents Chemother. 43:1317-1323.
11. Hancock, R. E. W., and A. Rozek. 2002. Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol. Lett. 206:143-149.
12. Hassett, D. J., and J. A. Imlay. 2007. Bactericidal antibiotics and oxidative stress: a radical proposal. ACS Chem. Biol. 2:708-710.
13. Hilpert, K., et al. 2006. Sequence requirements and an optimization strategy for short antimicrobial peptides. Chem. Biol. 13:1101-1107.
14. Hilpert, K., C. D. Fjell, and A. Cherkasov. 2008. Short linear cationic antimicrobial peptides: screening, optimizing, and prediction, p. 127-159. In L. Otvos (ed.), Peptide-based drug design. Humana Press, Totowa, NJ.
15. Hilpert, K., R. Volkmer-Engert, T. Walter, and R. E. W. Hancock. 2005. High-throughput generation of small antibacterial peptides with improved activity. Nat. Biotechnol. 23:1008-1012.
16. Hsu, C.-H., et al. 2005. Structural and DNA-binding studies on the bovine antimicrobial peptide, indolicidin: evidence for multiple conformations involved in binding to membranes and DNA. Nucleic Acids Res. 33:4053-4064. (Pubitemid 41487266)
17. Imlay, J. A., and S. Linn. 1988. DNA damage and oxygen radical toxicity. Science 240:1302-1309.
18. Kadurugamuwa, J. L., A. J. Clarke, and T. J. Beveridge. 1993. Surface action of gentamicin on Pseudomonas aeruginosa. J. Bacteriol. 175:5798-5805.
19. Kalapos, M. P. 2008. The tandem of free radicals and methylglyoxal. Chem. Biol. Interact. 171:251-271.
20. Katsui, N., et al. 1982. Heat-induced blebbing and vesiculation of the outer membrane of Escherichia coli. J. Bacteriol. 151:1523-1531. (Pubitemid 13230857)
21. Kohanski, M. A., D. J. Dwyer, B. Hayete, C. A. Lawrence, and J. J. Collins. 2007. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130:797-810.
22. Kohanski, M. A., D. J. Dwyer, J. Wierzbowski, G. Cottarel, and J. J. Collins. 2008. Mistranslation of membrane proteins and two-component system activation trigger antibiotic-mediated cell death. Cell 135:679-690.
23. Kragol, G., et al. 2001. The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding. Biochemistry 40:3016-3026. (Pubitemid 32206189)
24. Leonardo, M. R., Y. Dailly, and D. P. Clark. 1996. Role of NAD in regulating the adhE gene of Escherichia coli. J. Bacteriol. 178:6013-6018.
25. Mangoni, M. L., et al. 2004. Effects of the antimicrobial peptide temporin L on cell morphology, membrane permeability and viability of Escherichia coli. Biochem. J. 380:859-865. (Pubitemid 38850528)
26. Marcellini, L., M. Giammatteo, P. Aimola, and M. L. Mangoni. 2010. Fluorescence and electron microscopy methods for exploring antimicrobial peptides mode(s) of action. Methods Mol. Biol. 618:249-266.
27. Miller, C., et al. 2004. SOS response induction by β-lactams and bacterial defense against antibiotic lethality. Science 305:1629-1631. (Pubitemid 39296359)
28. Minahk, C. J., F. Dupuy, and R. D. Morero. 2004. Enhancement of antibiotic activity by sub-lethal concentrations of enterocin CRL35. J. Antimicrob. Chemother. 53:240-246.
29. Neidhardt, F. 1974. Culture medium for enterobacteria. J. Bacteriol. 119: 736-747.
30. Novo, D., N. G. Perlmutter, R. H. Hunt, and H. M. Shapiro. 1999. Accurate flow cytometric membrane potential measurement in bacteria using diethyloxacarbocyanine and a ratiometric technique. Cytometry 35:55-63.
31. Novo, D. J., N. G. Perlmutter, R. H. Hunt, and H. M. Shapiro. 2000. Multiparameter flow cytometric analysis of antibiotic effects on membrane potential, membrane permeability, and bacterial counts of Staphylococcus aureus and Micrococcus luteus. Antimicrob. Agents Chemother. 44:827-834.
32. Novogrodsky, A., A. Ravid, A. L. Rubin, and K. H. Stenzel. 1982. Hydroxyl radical scavengers inhibit lymphocyte mitogenesis. Proc. Natl. Acad. Sci. U. S. A. 79:1171-1174.
33. Patrzykat, A., C. L. Friedrich, L. Zhang, V. Mendoza, and R. E. W. Hancock. 2002. Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli. Antimicrob. Agents Chemother. 46:605-614.
34. Peschel, A., and H.-G. Sahl. 2006. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 4:529-536.
35. Podda, E., et al. 2006. Dual mode of action of Bac7, a proline-rich antibacterial peptide. Biochim. Biophys. Acta 1760:1732-1740.
36. Poole, R. K. 1994. Oxygen reactions with bacterial oxidases and globins: binding, reduction and regulation. Antonie Van Leeuwenhoek 65:289-310. (Pubitemid 24275122)
37. Russell, J. B., and G. M. Cook. 1995. Energetics of bacterial growth: balance of anabolic and catabolic reactions. Microbiol. Rev. 59:48-62.
38. Schneider, D. A., T. Gaal, and R. L. Gourse. 2002. NTP-sensing by rRNA promoters in Escherichia coli is direct. Proc. Natl. Acad. Sci. U. S. A. 99:8602-8607.
39. Shapiro, H. M. 2008. Flow cytometry of bacterial membrane potential and permeability, p. 175-186. In W. Scott Champney (ed.), New antibiotic targets. Humana Press, Totowa, NJ.
40. Shaw, J. E., J.-R. Alattia, J. E. Verity, G. G. Prive, and C. M. Yip. 2006. Mechanisms of antimicrobial peptide action: studies of indolicidin assembly at model membrane interfaces by in situ atomic force microscopy. J. Struct. Biol. 154:42-58.
41. Reference deleted.
42. Vlamis-Gardikas, A. 2008. The multiple functions of the thiol-based electron flow pathways of Escherichia coli: eternal concepts revisited. Biochim. Biophys. Acta 1780:1170-1200.
43. Westerhoff, H. V., D. Juretic, R. W. Hendler, and M. Zasloff. 1989. Magainins and the disruption of membrane-linked free-energy transduction. Proc. Natl. Acad. Sci. U. S. A. 86:6597-6601.
44. Wiegand, I., K. Hilpert, and R. E. W. Hancock. 2008. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat. Protoc. 3:163-175.
45. Wu, M., and R. E. W. Hancock. 1999. Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide. Antimicrob. Agents Chemother. 43:1274-1276.
46. Yonath, A. 2005. Antibiotics targeting ribosomes: resistance, selectivity, synergism, and cellular regulation. Annu. Rev. Biochem. 74:649-679.
47. Zhu, M. M., F. A. Skraly, and D. C. Cameron. 2001. Accumulation of methylglyoxal in anaerobically grown Escherichia coli and its detoxification by expression of the Pseudomonas putida glyoxalase I gene. Metab. Eng. 3:218-225.